Sandoz Drops Generic Mirapex Plans For Now
Sandoz Inc. has given up its fight to market a generic version of Boehringer Ingelheim International GmbH's Parkinson's drug Mirapex before Boehringer's patent on the drug expires in October in light...To view the full article, register now.
Already a subscriber? Click here to view full article